Showing results (31-40 of 162) with videos related to
Sort By:
Pageof 17
Drugs of Today (Barcelona, Spain : 1998)|September 16, 2003
Characterization of the hyporesponsiveness of synovial T-Cells in rheumatoid arthritis: role of chronic oxidative stressM M Maurice, C L Verweij, F C BreedveldThe Journal of Biological Chemistry|November 24, 1999
Functional disparity of distinct CD28 response elements toward mitogenic responsesA Civil, I Rensink, L A Aarden, et al.Genes and Immunity|February 20, 2004
Is there a future for TNF promoter polymorphisms?J-P Bayley, T H M Ottenhoff, C L VerweijEuropean Journal of Immunology|November 1, 1992
Evidence for a role of CD28RE as a response element for distinct mitogenic T cell activation signalsA Civil, M Geerts, L A Aarden, et al.The EMBO Journal|August 1, 1986
Full-length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunitC L Verweij, P J Diergaarde, M Hart, et al.The Journal of Rheumatology|October 24, 2001
Delayed referral of female patients with rheumatoid arthritisL R Lard, T W Huizinga, J M Hazes, et al.Transfusion|May 1, 1996
HLA class I-eluted platelets as an alternative to HLA-matched plateletsV M Novotny, T W Huizinga, R van Doorn, et al.Immunopharmacology|March 1, 1996
Inflammatory and immunological parameters of disease activity in rheumatoid arthritis patients treated with minocyclineM Kloppenburg, B A Dijkmans, C L Verweij, et al.European Journal of Biochemistry|March 14, 1991
Effect of deletion of the A1 domain of von Willebrand factor on its binding to heparin, collagen and platelets in the presence of ristocetinJ J Sixma, M E Schiphorst, C L Verweij, et al.Clinical and Experimental Rheumatology|January 27, 2004
Active MMPs captured by alpha 2 macroglobulin as a marker of disease activity in rheumatoid arthritisI Tchetverikov, N Verzijl, T W Huizinga, et al.Pageof 17